JMPHF (Leveljump Healthcare) Moat Score: 1/10 (As of Jun. 30, 2026)


What is Leveljump Healthcare Moat Score?

Leveljump Healthcare JMPHF Moat Score is 1 as of Jun. 30, 2026. The stock has 2 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, Leveljump Healthcare ranks better than 65.74% on this metric.

Leveljump Healthcare has the Moat Score of 1, which implies that the company might have No Moat - Very weak/transient advantages.

Leveljump Healthcare has No Moat: Leveljump Healthcare operates in a highly competitive healthcare sector with minimal market share and lacks significant intellectual property, brand strength, or cost advantages to establish a durable competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Leveljump Healthcare might have No Moat - Very weak/transient advantages.

Leveljump Healthcare  (OTCPK:JMPHF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Leveljump Healthcare Moat Score Related Terms

JMPHF vs TMO, DHR, IDXX: Moat Score Comparison

For the Diagnostics & Research subindustry, Leveljump Healthcare's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Leveljump Healthcare Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Leveljump Healthcare's Moat Score distribution charts can be found below:

* The bar in red indicates where Leveljump Healthcare's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 1 mean?
Leveljump Healthcare (JMPHF) has a Moat Score of 1 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Leveljump Healthcare ranks #74 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 34.3%.
Is Leveljump Healthcare's Moat Score too high?
Leveljump Healthcare's current Moat Score is 1. Based on the distribution chart, Leveljump Healthcare ranks #74 out of 216 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does Leveljump Healthcare's Moat Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Leveljump Healthcare ranks #74 out of 216 companies for Moat Score. This puts Leveljump Healthcare in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Leveljump Healthcare's current Moat Score is 1. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leveljump Healthcare stock overvalued right now?
Leveljump Healthcare (JMPHF) has a current Moat Score of 1. The stock's GF Value™ is $0.05, compared to a current price of $0.04 — trading 14.5% below its estimated fair value. The current Moat Score is 1. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Leveljump Healthcare (JMPHF), the current Moat Score is 1 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Leveljump Healthcare Business Description

Other Exchanges JUMP:Canada
Address 52 Scarsdale Road, Suite 207, Toronto, ON, CAN, M3B 2R7
Leveljump Healthcare Corp is engaged in providing radiology services both by providing direct patient images and by providing Teleradiology services, which is the process of providing remote off-site reading of radiology scans such as CT, MRI, and X-ray. Its teleradiology services allow hospital staff to scan their emergency room patients, then page the company's radiologist on call, who can then remotely view, via a secured server, the images and diagnose the patient, and provide a report back to the hospital. Leveljump provides its direct-to-patient services at its Independent Healthcare Facilities (IHFs). The company operates as a single segment, with all of its core assets, intellectual property, and development work being conducted in Canada.